---
figid: PMC5817859__12943_2018_793_Fig2_HTML
figtitle: Alternative downstream compounds-induced EGFR-TKIs resistance
organisms:
- NA
pmcid: PMC5817859
filename: 12943_2018_793_Fig2_HTML.jpg
figlink: /pmc/articles/PMC5817859/figure/Fig2/
number: F2
caption: 'Alternative downstream compounds-induced EGFR-TKIs resistance. 1. PTEN loss:
  suppressed HGR1 downregulates PTEN expression which in general inhibits the PI3K/Akt
  activation. 2. PIK3CA mutation-drived abnormal activation of PI3K pathway. 3. BRAF
  mutation-drived abnormal activation of MAPK signaling axis'
papertitle: EGFR-TKIs resistance via EGFR-independent signaling pathways.
reftext: Qian Liu, et al. Mol Cancer. 2018;17:53.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9555431
figid_alias: PMC5817859__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC5817859__F2
ndex: 577acab1-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5817859__12943_2018_793_Fig2_HTML.html
  '@type': Dataset
  description: 'Alternative downstream compounds-induced EGFR-TKIs resistance. 1.
    PTEN loss: suppressed HGR1 downregulates PTEN expression which in general inhibits
    the PI3K/Akt activation. 2. PIK3CA mutation-drived abnormal activation of PI3K
    pathway. 3. BRAF mutation-drived abnormal activation of MAPK signaling axis'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Ras64B
  - Ras85D
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Raf
  - Pten
  - Dsor1
  - Mtk
  - Akt
  - Erk7
  - rl
  - Mtor
  - Tor
  - Egfr
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EGR1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PTEN
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - EGFR
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
